Seraphina Therapeutics Hits Significant Regulatory Milestone, Earning GRAS Status for FA15™
SAN DIEGO , June 24 /Businesswire/ - “Now, companies can include this powerful ingredient as a fortifier to their products, helping far more people make up for nutritional deficiencies and take charge of their health," said Dr. Stephanie Venn-Watson, CEO of Seraphina Therapeutics.